+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India



Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India



Indian Journal of Medical Microbiology 31(1): 60-63



Multidrug-resistant (MDR) Acinetobacter baumannii is a worldwide concern as cause of serious nosocomial infections. We analysed 140 non-duplicate Acinetobacter sp. isolates from hospitalised patients in a tertiary care centre; 87% were MDR and 20% (28/140) meropenem resistant. Metallo-β-lactamase was produced by 16 of these, detected by ethylene-diamine-tetra-acetic acid disc synergy test. AmpC β-lactamase and efflux pump were present in 17 and 4 of the meropenem-resistant Acinetobacter, respectively. 9/16 MBL-positive isolates carried genes for carbapenem resistance as shown by polymerase chain reaction.

(PDF emailed within 0-6 h: $19.90)

Accession: 051519969

Download citation: RISBibTeXText

PMID: 23508431

DOI: 10.4103/0255-0857.108724


Related references

Molecular Characterization of Carbapenem Resistant Isolates of Acinetobacter baumannii in An Intensive Care Unit of A Tertiary Care Centre at Central India. Journal of Clinical and Diagnostic Research 8(5): Dc38-Dc40, 2014

Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India. Infectious Diseases and Therapy 5(3): 379-387, 2016

Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant iAcinetobacter baumannii at a Tertiary Care Hospital from South India. Journal of Clinical and Diagnostic Research 10(9): Dc15-Dc18, 2016

Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. Journal of Health, Population, and Nutrition 26(2): 183-188, 2008

High prevalence of carbapenem resistant Pseudomonas aeruginosa at a tertiary care centre of north India. Are we under-reporting?. Indian Journal of Medical Research 128(3): 324-325, 2008

Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 30(2): 187-189, 2007

Median Hospitalization Cost and Length of Stay for Carbapenem-Resistant Verse Carbapenem-Sensitive Patients in a Tertiary Care Hospital in South India. Value in Health 17(7): A669-A669, 2014

Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey. Fems Microbiology Letters 282(2): 214-218, 2008

In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt. Journal of Infection and Public Health 8(6): 593-602, 2016

Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clinical Microbiology and Infection 13(5): 490-496, 2007

Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital. Journal of Antimicrobial ChemoTherapy 52(6): 1046-1047, 2003

Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiologica 37(1): 65-73, 2014

Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. Journal of Clinical Microbiology 43(9): 4826-4829, 2005

Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific. Scandinavian Journal of Infectious Diseases 42(11-12): 821-826, 2011

In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant Acinetobacter species: report from a tertiary care centre in Karachi, Pakistan. ChemoTherapy 56(3): 184-189, 2011